Treatment of decrease in desire to eat with Unani medicine Safoof Hazim Kalan

Phase 3

Not yet recruiting

• Conditions: Anorexia,

• Registration Number: CTRI/2023/01/048981
• Lead Sponsor: Central Council for Research in Unani Medicine (CCRUM), New Delhi

Brief Summary

This study is designed as a single centric open trial in patients with Zof e lshteha (Anorexia). After screening, patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically on 7th and 14th day. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 2 weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

**Composition of Safoof Hazim Kalan**



| | | |

| --- | --- | --- |

|**S.No.**

**Ingredients**

**Quantity**

|1.

Post Halela Zard

20g

|2.

Post Balela

20g

|3.

Aamla

20g

|4.

Badiyan

20g

|5.

Nankhwah

20g

|6.

Zeera Safaid

20g

|7.

Namak-E-Sang

20g

|8.

Namak Siya

20g

|9.

Namak Hindi

20g

|10.

Jawakhar

20g

|11.

Tankar Biryan

10g

|12.

Naushadar

10g

|13.

Filfil Siyah

10g

|14.

Dana Heel Khurd

10g

|15.

Zanjabeel

10g

|16.

Filfil Daraz

10g

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-17
• Last Update Posted: 2023-06-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Patients of any sex in the age group 18-65 years.
• Patients having Zof e lshteha(Anorexia) with SNAQ score≤14.

Exclusion Criteria

• Patients having Anorexia nervosa 2.
• Patients having any systemic disease,chronic debilitating disease,T.B.,Diabetes Mellitus etc.
• Known cases of Hepatic,Renal or Cardiac Ailments 4.
• History of hypersensitivity to study drug or any of its ingredients.
• History of addiction (Alcohol,Drugs) 6.
• Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in sign and symptoms of Zof e lshteha (Anorexia) on the basis of improvement in the appetite for which the Simplified Nutritional Appetite Questionnaire (SNAQ)	On baseline, 7th day and 14th day

Secondary Outcome Measures

Name	Time	Method
Haematological and biochemical assessment for safety assessment	At baseline and end of the treatment i.e. 14th day

Trial Locations

Locations (1)

Regional Research Institute of Unani Medicine (RRIUM), Aligarh; 🇮🇳 Aligarh, UTTAR PRADESH, India

Regional Research Institute of Unani Medicine (RRIUM), Aligarh

🇮🇳Aligarh, UTTAR PRADESH, India

Dr Rashid ul Islam

Principal investigator

9897975161

waytorashid@gmail.com